CVS HEALTH CORPORATION (CVS) — 分析摘要
CVS HEALTH CORPORATION（CVS）的市值为133.30十亿美元，最近一年的营收同比增长了+7.8%。净利润率为0.4%。当前市盈率为45.5倍。
核心要点
- 营收同比变化+7.8%
- 净利润率0.4%
- 市盈率45.5倍
与RETAIL-DRUG STORES AND PROPRIETARY STORES板块的其他公司相比，CVS的营收增长为+7.8%，市盈率为45.5倍。
CVS HEALTH CORPORATION (CVS)
更新 — ET · 来源 POLYGON
红旗与风险提示高风险信号
存在多项实质性红旗，在依赖任何估值输出前应先重点核查这些风险。
Debt/EBITDA 为 5.7x — 杠杆偏高
利息保障倍数为 1.9x — 应对盈利下滑空间有限
流动比率为 0.87x — 流动负债超过流动资产
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
行业
RETAIL-DRUG STORES AND PROPRIETARY STORES
员工人数
300,000
总部
WOONSOCKET, RI
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$2.66
股息收益率
2.59%
股息历史
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。